Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Hemasphere|February 19, 2021
Hemophilia Gene Therapy: Approaching the First Licensed ProductPaul Batty, David LillicrapInternational Journal of Laboratory Hematology|July 21, 2021
Gene therapy for hemophilia: Current status and laboratory consequencesPaul Batty, David LillicrapHuman Molecular Genetics|July 24, 2019
Advances and challenges for hemophilia gene therapyPaul Batty, David LillicrapJournal of Thrombosis and Haemostasis : JTH|August 3, 2024
Adeno-associated viral vector integration: implications for long-term efficacy and safetyPaul Batty, David LillicrapBritish Journal of Haematology|February 18, 2020
Advances in knowledge of inhibitor formation in severe haemophilia AMatthew Cormier, Paul Batty, Julie Tarrant, et al.Therapeutic Advances in Hematology|February 2, 2026
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expressionSylvia Fong, Laura L Swystun, Paul Batty, et al.Thrombosis Research|May 11, 2007
Von Willebrand disease - phenotype versus genotype: deficiency versus diseaseDavid LillicrapHematology. American Society of Hematology. Education Program|November 25, 2006
The role of immunomodulation in the management of factor VIII inhibitorsDavid LillicrapHematology. American Society of Hematology. Education Program|December 10, 2013
von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapyDavid LillicrapHaemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
The World Federation of Hemophilia and researchDavid LillicrapPageof 19